Projected Prevalence and Economic Burden of Alzheimer’s Disease and Related Dementias in China: Regional Disparities and Policy Implications
Health Data Science · 2025-01 · 5
DOI: 10.34133/hds.0377 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Data Science, online erschienen am 21.11.2025. Verfasst von Xinyi Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.
Themen: Demenz
Abstract (Originalsprache)
Background
China has the largest population with Alzheimer’s disease and related dementias (ADRDs) globally, and rapid population aging is expected to drive a substantial increase in cases. This study projects ADRD prevalence and associated economic burdens across provinces in China from 2025 to 2060.
Methods
Using data from the China Health and Retirement Longitudinal Study (CHARLS) supplemented by national demographic and provincial statistics, we projected the prevalence and care costs of ADRD for each of the 31 provinces in China from 2025 to 2060. Cost projections included formal care expenses and informal caregiving valued through replacement cost methods. We conducted uncertainty analysis to provide robust estimates for ADRD prevalence and costs.
Results
By 2060, ADRD cases in China are projected to reach approximately 49.89 million, with the highest prevalence and economic burden concentrated in provinces such as Shandong, Sichuan, Jiangsu, Henan, and Guangdong. Formal care costs alone are expected to exceed $1 trillion annually, while the total economic value—including informal caregiving—could surpass $5 trillion. Geographic disparities highlight that Eastern and Central regions, with a higher proportions of older adults, will bear disproportionate costs. Informal caregiving is projected to constitute 60% to 80% of total ADRD-related costs.
Conclusion
China faces an unprecedented rise in ADRD-related economic burden over the next 4 decades, with substantial regional disparities. Strengthening long-term care infrastructure, expanding financial and social support for caregivers, and implementing regionally tailored healthy aging policies are essential to ensuring equitable and sustainable ADRD care across China.
Autor:innen und Institutionen
- School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Heidelberg Institute of Global Health, Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany.
- State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, China.
- Center for Population Health and Health Services Research, Department of Foundations of Medicine, New York University Grossman Long Island School of Medicine, Mineola, NY, USA.
- Department of Population Health, New York University Grossman School of Medicine, New York, NY, USA.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, X., Chen, S., Zhang, D., Gu, Y., Li, G., Wu, B., Pagán, J. A., Zhang, L., & Li, Y. (2025). Projected Prevalence and Economic Burden of Alzheimer’s Disease and Related Dementias in China: Regional Disparities and Policy Implications. Health Data Science, 5. https://doi.org/10.34133/hds.0377
Vancouver
Liu X, Chen S, Zhang D, Gu Y, Li G, Wu B, et al. Projected Prevalence and Economic Burden of Alzheimer’s Disease and Related Dementias in China: Regional Disparities and Policy Implications. Health Data Science. 2025;5. doi:10.34133/hds.0377
BibTeX
@article{Liu2025,
author = {Liu, Xinyi and Chen, Simiao and Zhang, Donglan and Gu, Yian and Li, Gang and Wu, Bei and Pagán, José A and Zhang, Luxia and Li, Yan},
title = {Projected Prevalence and Economic Burden of Alzheimer’s Disease and Related Dementias in China: Regional Disparities and Policy Implications},
journal = {Health Data Science},
year = {2025},
volume = {5},
doi = {10.34133/hds.0377}
}
EUVIMED